Member access

4-Traders Homepage  >  Shares  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)

297
Delayed Quote. Delayed Euronext Bruxelles - 11/27 10:46:19 am
62.54 EUR   +0.29%
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
11/07 Belgium's UCB to sell generics unit for 964 million pounds
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
11/21/2014 11/24/2014 11/25/2014 11/26/2014 11/27/2014 Date
60.95(c) 61(c) 61.66(c) 62.36(c) 62.54 Last
250 609 227 077 371 095 225 000 89 450 Volume
-1.14% +0.08% +1.08% +1.14% +0.29% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
02/25Earnings Release
Surperformance© rating of UCB
Trading Rating : Investor Rating :
More about the company
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 506 M
EBIT 2014 498 M
Net income 2014 247 M
Debt 2014 1 432 M
Yield 2014 1,71%
Sales 2015 3 778 M
EBIT 2015 641 M
Net income 2015 359 M
Debt 2015 1 192 M
Yield 2015 1,93%
PER 2014 48,50
PER 2015 30,90
EV / Sales 2014 3,87x
EV / Sales 2015 3,53x
Capitalization 12 129 M
More Financials
Latest news on UCB
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
11/07 Belgium's UCB to sell generics unit for 964 million pounds
10/22 EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
10/21UCB SA : quaterly earnings release
10/08 UCB : Georgia Bio and UCB to Host Parkinson's Gala Benefitting the National Park..
09/26 UCB : Acquisition of own shares
09/24 UCB : Patent Application Titled "Systems and Methods for Administering Medicatio..
09/23 Pending 'inversions' that new U.S. Treasury rules may hit
09/17 UCB : Patent Issued for Method for Producing Protein
09/11 Eastman Chemical to buy Taminco for $1.8 bln
09/10 UCB : Patent Application Titled "Pharmaceutical Composition Comprising Rotigotin..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF